|
Women who work nights and those who are
up frequently during the early hours of the morning may be
at increased risk for developing breast cancer.
The findings, combined with those of
other studies in humans and in animals, suggest that nighttime
exposure to light may elevate breast cancer risk by suppressing
production of melatonin, a brain hormone that is made during
darkness and that normally peaks at night.
Nighttime light exposure can come from
a variety of sources, including
working the night shift, having insomnia or even being exposed
to light in the bedroom during sleep.
Breast cancer risk was higher among women
who often did not sleep during the period of the night when
levels of the sleep-regulating hormone melatonin are typically
at their highest, the study indicates. Their breast cancer
risk increased 14% for each night of the week that they reported
not sleeping during this period.
Working the graveyard shift upped a woman's
risk of developing breast cancer by 60%.
The results of this study provide evidence
that indicators of exposure to light at night may be associated
with the risk of developing breast cancer.
Researchers from Harvard Medical School
also examined the relationship between breast cancer and working
the night shift in more than 78,000 nurses.
Women who worked between 1 and 29 years
on a rotating night-shift schedule had an 8%
increase in breast cancer risk, while women who
worked 30 or more years on the night shift showed a 36%
increase in their risk of developing breast cancer.
Women who work on rotating night shifts
with at least 3 nights per month, in addition to days and
evenings in that month, appear to have a moderately increased
risk of breast cancer after extended periods of working rotating
night shifts.
Evidence is accumulating for an association
between exposure to light at night and breast cancer risk.
One possible explanation for this relationship
has to do with melatonin production. Melatonin is produced
by the brain's pineal gland. Because it is released into the
bloodstream at night, the hormone is thought to play a role
in regulating sleep.
When normal melatonin cycles are interrupted
in women, the production of estrogen from the ovaries
is higher and this may contribute to their breast
cancer risk.
The new studies add to a large body of
research that has raised concerns about the long-term health
effects of work schedules that involve irregular hours and
frequent changes between day and night duty -- schedules that
have become increasingly common.
Night-shift work is associated with an
increased risk for heart disease, digestive tract disorders
and pregnancy complications. Researchers are planning studies
to explore whether it affects the risk for prostate cancer
or other tumors.
Exposure to light at night, by suppressing
melatonin production, may
increase women's levels of the sex hormone estrogen,
which stimulates growth of breast tissue, including some breast
cancers.
Blind women, whose melatonin production
does not drop upon exposure to light, have lower breast cancer
rates than sighted women. Laboratory studies and experiments
in animals suggest that melatonin may directly inhibit the
growth of breast cancer cells.
Journal of
the National Cancer Institute October 17, 2001;93:1513-1515,
1557-1568
|